HOMENews&Events 2019年 IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma
2019 News
19.08.02
IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma
(19.08.02)
The research group of University of Cincinnati, Hiroshima University and Keio University, published the findings of a new study entitled " IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma" in Nature Cell Biology on August 2, 2019.
LINK